216 related articles for article (PubMed ID: 24890273)
1. Has noninvasive fetal trisomy testing (NIFTY) rung the death knell for other forms of prenatal testing?
Parikh FR; Panpalia M; Khandeparkar M
Fertil Steril; 2014 Jul; 102(1):34-5. PubMed ID: 24890273
[No Abstract] [Full Text] [Related]
2. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
[TBL] [Abstract][Full Text] [Related]
3. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
[TBL] [Abstract][Full Text] [Related]
4. Overall evaluation of the clinical value of prenatal screening for fetal-free DNA in maternal blood.
Yu B; Lu BY; Zhang B; Zhang XQ; Chen YP; Zhou Q; Jiang J; Wang HY
Medicine (Baltimore); 2017 Jul; 96(27):e7114. PubMed ID: 28682865
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population.
Nicolaides KH; Syngelaki A; Ashoor G; Birdir C; Touzet G
Am J Obstet Gynecol; 2012 Nov; 207(5):374.e1-6. PubMed ID: 23107079
[TBL] [Abstract][Full Text] [Related]
6. [Non-invasive prenatal diagnosis of the most common aneuploidies with cell-free fetal DNA in maternal serum--preliminary results].
Bijok J; Gorzelnik K; Massalska D; Ilnicka A; Pawłowska B; Zimowski JG; Kucińska-Chahwan A; Jakiel G; Roszkowski T
Ginekol Pol; 2014 Mar; 85(3):208-13. PubMed ID: 24783433
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive prenatal testing: the importance of pretest trisomy risk and posttest predictive values.
Wax JR; Chard R; Cartin A; Litton C; Pinette MG; Lucas FL
Am J Obstet Gynecol; 2015 Apr; 212(4):548-9. PubMed ID: 25555658
[No Abstract] [Full Text] [Related]
8. Detection of chromosome abnormalities using current noninvasive prenatal testing: A multi-center comparative study.
Du Y; Lin J; Lan L; Dong Y; Zhu J; Jiang W; Pan X; Lu Y; Li D; Wang L
Biosci Trends; 2018 Jul; 12(3):317-324. PubMed ID: 29952350
[TBL] [Abstract][Full Text] [Related]
9. [Non-invasive fetal trisomy (NIFTY) test in prenatal diagnosis].
Łaczmańska I; Stembalska A
Ginekol Pol; 2014 Apr; 85(4):300-3. PubMed ID: 24834709
[TBL] [Abstract][Full Text] [Related]
10. Circulating Cell-free DNA and Screening for Trisomies.
Norton ME
N Engl J Med; 2022 Oct; 387(14):1322-1324. PubMed ID: 36170494
[No Abstract] [Full Text] [Related]
11. Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method.
Ashoor G; Syngelaki A; Wang E; Struble C; Oliphant A; Song K; Nicolaides KH
Ultrasound Obstet Gynecol; 2013 Jan; 41(1):21-5. PubMed ID: 22996646
[TBL] [Abstract][Full Text] [Related]
12. Cell-free DNA screening in clinical practice: abnormal autosomal aneuploidy and microdeletion results.
Valderramos SG; Rao RR; Scibetta EW; Silverman NS; Han CS; Platt LD
Am J Obstet Gynecol; 2016 Nov; 215(5):626.e1-626.e10. PubMed ID: 27371353
[TBL] [Abstract][Full Text] [Related]
13. A new era in noninvasive prenatal testing.
Morain S; Greene MF; Mello MM
N Engl J Med; 2013 Aug; 369(6):499-501. PubMed ID: 23862975
[No Abstract] [Full Text] [Related]
14. Sequential pathways of testing after first-trimester screening for trisomy 21.
Platt LD; Greene N; Johnson A; Zachary J; Thom E; Krantz D; Simpson JL; Silver RK; Snijders RJ; Goetzl L; Pergament E; Filkins K; Mahoney MJ; Hogge WA; Wilson RD; Mohide P; Hershey D; MacGregor S; Bahado-Singh R; Jackson LG; Wapner R;
Obstet Gynecol; 2004 Oct; 104(4):661-6. PubMed ID: 15458882
[TBL] [Abstract][Full Text] [Related]
15. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.
Karadzov-Orlić N; Egić A; Filimonović D; Marinković M; Damnjanović-Pazin B; Milovanović Z; Joksić I; Branković S; Lukić R; Mandić V; Cerović N; Mojović D; Plamenac S; Stanković M; Maglić D; Mikovć Z
Srp Arh Celok Lek; 2012; 140(9-10):606-11. PubMed ID: 23289277
[TBL] [Abstract][Full Text] [Related]
16. Limited value of echography to predict true fetal mosaicism for trisomy 12.
Gentilin B; Giardino D; Boschetto C; Guerneri S; Fortuna R; Rizzuti T; Lalatta F
Prenat Diagn; 2006 Dec; 26(12):1186-9. PubMed ID: 17115457
[No Abstract] [Full Text] [Related]
17. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis.
Mackie FL; Hemming K; Allen S; Morris RK; Kilby MD
BJOG; 2017 Jan; 124(1):32-46. PubMed ID: 27245374
[TBL] [Abstract][Full Text] [Related]
18. Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities?
Gerovassili A; Garner C; Nicolaides KH; Thein SL; Rees DC
Prenat Diagn; 2007 Feb; 27(2):104-10. PubMed ID: 17152117
[TBL] [Abstract][Full Text] [Related]
19. Sequential pathways of testing after first-trimester screening for trisomy 21.
Malone FD
Obstet Gynecol; 2005 Feb; 105(2):438; author reply 438-9. PubMed ID: 15684179
[No Abstract] [Full Text] [Related]
20. Individualized correction for maternal weight in calculating the risk of chromosomal abnormalities with first-trimester screening data.
Merz E; Thode C; Eiben B; Faber R; Hackelöer BJ; Huesgen G; Pruggmaier M; Wellek S
Ultraschall Med; 2011 Feb; 32(1):33-9. PubMed ID: 21305437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
